What population, site, comparator and outcome were studied?
- Evidence rule
- Keep simulation, retrospective analysis and clinical evidence clearly separated.
FUURAA™ · 2026 AI Frontier Technology Radar
Biology, Health & Digital Life
Trace AI across biology, medicine, health systems, longevity research and the emerging representation of human life in data.
Watch thesis
Health and life-science evidence must distinguish retrospective datasets, simulation, laboratory validation, prospective studies and real clinical outcomes.
Applicability boundaryThis observatory provides research analysis, not medical advice, clinical approval or proof of benefit for an individual.
This page separates canonical sources, FUURAA original summaries and analysis. Inclusion does not imply partnership, endorsement or approval.
What this lens tracks
Declare the observation boundary before admitting a new development into the evidence chain.
- 01biomedical models, agents and data analysis
- 02diagnostics, treatment support and health operations
- 03genomics, longevity and digital-life systems
Three evidence questions
Ask not only what happened, but how far the evidence travels.
Was performance prospectively validated in real practice?
- Evidence rule
- Preserve population, geography, subgroup and workflow boundaries.
How are privacy, consent, access, bias and human responsibility handled?
- Evidence rule
- Do not convert research findings into individual medical advice.
Verified primary sources
4 directly relevant 2026 source records for this lens.
Each record states its publication date, source organisation, evidence type, FUURAA original summary and known boundary.
22 July 2026 · Nature Biomedical EngineeringCLEAR: an auditable foundation model for radiology grounded in clinical concepts
Evidence statusPrimary source · Research
CLEAR maps chest X-rays into a large clinical-concept space so predictions can be decomposed and audited, with external evaluation datasets from the United States, Europe and Asia.
Open canonical source ↗17 June 2026 · NatureTowards autonomous medical artificial intelligence agentsEvidence statusPrimary source · Research
MIRA operates in a sandboxed electronic-health-record environment to gather histories, order and interpret tests, and formulate treatment plans.
Evidence boundaryThe reported results are simulation-based; prospective real-world safety and governance studies remain necessary.
Open canonical source ↗19 May 2026 · Nature / Google DeepMindAccelerating scientific discovery with Co-ScientistEvidence statusPrimary source · Research
Co-Scientist uses multiple Gemini-based agents to generate, debate and refine hypotheses; selected proposals in drug repurposing, liver fibrosis and antimicrobial resistance received wet-lab testing.
Open canonical source ↗30 March 2026 · Nature Biomedical EngineeringEmpowering AI data scientists using a multi-agent LLM framework with self-evolving capabilities for autonomous, tool-aware biomedical data analysesEvidence statusPrimary source · Research
BioMedAgent learns to combine bioinformatics tools into executable workflows and was evaluated across hundreds of biomedical-analysis tasks, including cross-omics work and pathology-image segmentation.
Open canonical source ↗FUURAA analysis
The highest-value systems will connect biological evidence, clinical workflow and human agency without treating people as interchangeable data points.
How to use this lensUse these records as a starting point for continuing observation—not as a complete market map, investment advice, certification conclusion or certain forecast. Source updates, version changes and independent replication can change the assessment.
Continue across the nine lenses
Technical progress often crosses model, infrastructure, deployment and governance boundaries.
Models & Multimodal IntelligenceAgents, Tools & Digital InfrastructureRobotics & Embodied IntelligenceChips, Compute, Data & EnergyAutonomous Laboratories & Experiment SystemsScientific Intelligence & DiscoveryBiology, Health & Digital LifeReal Products, Work & DeploymentSafety, Evaluation, Policy & SocietyReturn to the 2026 AI Frontier Technology Radar